Skip to search formSkip to main contentSkip to account menu

Leishmaniasis, Visceral

Known as: azar kala, Leishmaniasis, Visceral [Disease/Finding], Black Fever 
A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is… 
National Institutes of Health

Related topics

Related topics

17 relations
Amphotericin 100mg powder for infusion solution vialAmphotericin BAmphotericin B Colloidal DispersionIn Blood

Broader (1)

Leishmaniasis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Leishmaniasis chemotherapy--challenges and opportunities.
Although there have been significant advances in the treatment of visceral leishmaniasis (VL), there remain challenges to ensure… 
Review
2007
Review
2007
Balancing immunity and pathology in visceral leishmaniasis
Experimental visceral leishmaniasis (VL) caused by infection with Leishmania donovani results in the development of organ… 
Review
2007
Review
2007
Chemotherapy of leishmaniasis: past, present and future.
Leishmaniasis is a parasitic disease caused by hemoflagellate, Leishmania spp. The parasite is transmitted by the bite of an… 
Review
2006
Review
2006
Drug Resistance in Leishmaniasis
SUMMARY Leishmaniasis is a complex disease, with visceral and cutaneous manifestations, and is caused by over 15 different… 
Review
2006
Review
2006
Visceral leishmaniasis - current therapeutic modalities.
Major therapeutic obstacles in the treatment of visceral leishmaniasis (VL) include the alarming increase in antimonial… 
Highly Cited
2002
Highly Cited
2002
Comparison of Six PCR Methods Using Peripheral Blood for Detection of Canine Visceral Leishmaniasis
ABSTRACT The objectives of this study were to compare the sensitivities and reliabilities of different PCR methods for the… 
Highly Cited
2001
Highly Cited
2001
Drug resistance in Indian visceral leishmaniasis
Throughout the world, pentavalent antimonial compounds (Sbv) have been the mainstay of antileishmanial therapy for more than 50… 
Highly Cited
1999
Highly Cited
1999
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.
BACKGROUND There is no effective orally administered medication for any leishmania infection. We investigated miltefosine, which… 
Highly Cited
1986
Highly Cited
1986
New perspectives on a subclinical form of visceral leishmaniasis.
During an epidemiological study of visceral leishmaniasis in an endemic region of Brazil, new perspectives emerged on a… 
Highly Cited
1983
Highly Cited
1983
Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis.
During a 20-month period, more than 500 splenic aspirations were performed in 89 patients with suspected or proven visceral… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)